Control arm n=150 | Non-improved cases n=880 | Improved cases n=350 | Test of significance | Test of sig. | |
---|---|---|---|---|---|
Age/years | 58.33±8.16 | 57.14±6.88 | 53.43±9.33 | F=3.47 P=0.034* | P1=0.579 P2=0.041* P3=0.017* |
Sex | |||||
Male | 60 (40.0) | 340 (38.6) | 210 (60.0) | χ2=4.75 | p1=0.92 p2=0.19 p3=0.032* |
Female | 90 (60.0) | 540 (61.4) | 140 (40.0) | P=0.093 | |
DM | 30 (20.0) | 310 (35.2) | 40 (11.4) | MC P=0.023* | p1=0.246 p2=0.423 p3=0.008* |
Hypertension | 30 (20.0) | 130 (14.8) | 30 (8.6) | MC P=0.506 | p1=0.699 p2=0.348 p3=0.356 |
Associated comorbidities | |||||
−VE | 20 (13.3) | 80 (9.1) | 20 (5.7) | MC P=0.665 | p1=0.608 |
+VE | 130 (86.7) | 800 (90.9) | 330 (94.3) | p2=0.574 p3=0.723 | |
Spleen US | |||||
1 | 13.57±3.19 | 13.63±2.39 | 12.37±1.61 | F=3.74, P=0.026* | p1=0.92, p2=0.09, p3=0.008* |
2 | 13.03±2.75 | 13.40±2.33 | 12.09±1.50 | F=4.45, P=0.013* | p1=0.55, p2=0.16, p3=0.003* |
3 | 12.75±2.14 | 13.21±1.31 | 11.91±1.31 | F=5.74, P=0.004* | p1=0.41, p2=0.17, p3=0.001* |
Portal vein US | |||||
1 | 12.40±2.92 | 12.81±2.44 | 10.40±1.75 | F=13.29, P<0.001* | p1=0.54, p2=0.006*, p3<0.001* |
2 | 12.13±2.79 | 12.58±2.41 | 10.09±1.46 | F=15.42, P=0.001* | p1=0.48, p2=0.004*, p3=0.001* |
3 | 11.50±2.28 | 12.35±2.42 | 9.89±1.25 | F=16.1, P=0.001* | p1=0.17, p2=0.02*, p3=0.001* |
ALT | |||||
1 | 32 (15–88) | 24.5 (6–60) | 34 (2–78) | KW, P=0.001* | p1=01*, p2=0.82, p3<0.001* |
2 | 28 (15–59) | 25 (10–128) | 28 (16–46) | KW, P=0.23 | p1=0.17, p2=0.65, p3=0.20 |
3 | 28 (18–43) | 24 (8–86) | 26 (10–43) | KW, P=0.09 | p1=0.05, p2=0.22, p3=0.25 |
AST | |||||
1 | 38 (17–94) | 34 (11–85) | 38 (19–71) | KW, P=0.04* | p1=0.14, p2=0.92, p3=0.02* |
2 | 32 (17–79) | 28 (11–92) | 26 (13–62) | KW, P=0.057 | p1=0.27, p2=0.025*, p3=0.07 |
3 | 28.5 (20–45) | 28.5 (7–96) | 23 (14–45) | KW, P=0.003* | p1=0.61, p2=0.024*, p3=0.001* |
Platelet | |||||
1 | 147 (57–259) | 126.5 (33–256) | 196 (60–343) | KW, P=0.001* | p1=0.47, p2=0.07, p3=0.001* |
2 | 154 (61–355) | 138.5 (30–344) | 187 (72–374) | KW, P=0.001* | p1=0.12, p2=0.53, p3<0.001* |
3 | 138.5 (30–344) | 134 (37–259) | 184 (60–333) | KW, P=0.001* | p1=0.24, p2=0.19, p3<0.001* |
Hb | |||||
1 | 13.45±1.19 | 12.8±1.58 | 13.11±1.27 | F=1.08, P=0.342 | p1=.17, p2=0.46, p3=0.44 |
2 | 13.20±0.95 | 13.05±1.40 | 13.20±1.31 | F=0.21, P=0.81 | p1=0.682, p2=0.99, p3=0.563 |
3 | 12.79±0.79 | 13.15±1.19 | 13.29±1.22 | F=0.92, P=0.40 | p1=0.286, p2=0.17, p3=0.54 |
WBCS | |||||
1 | 7.62±2.14 | 5.85±2.35 | 6.61±2.61 | F=4.06, P=0.019* | p1=0.009*, p2=0.17, p3=0.11 |
2 | 6.83±2.05 | 5.78±1.94 | 6.08±2.32 | F=1.74, P=0.179 | p1=0.07, p2=0.24, p3=0.47 |
3 | 6.04±1.39 | 5.81±1.72 | 6.03±2.06 | F=0.232, P=0.793 | p1=0.66, p2=0.98, p3=0.55 |
Bilirubin | |||||
1 | 0.887±0.43 | 0.931±0.441 | 0.902±0.34 | F=0.11, P=0.896 | p1=0.70, p2=0.90, p3=0.73 |
2 | 0.931±0.44 | 0.902±0.34 | 1.05±1.0 | F=0.59, P=0.55 | p1=0.50, p2=0.29, p3=0.48 |
3 | 0.96±0.45 | 1.04±0.61 | 0.860±0.21 | F=1.53, P=0.22 | p1=0.61, p2=0.52, p3=0.08 |
Albumin | |||||
1 | 3.93±0.53 | 4.13±0.39 | 4.22±0.37 | F=2.54, P=0.082 | p1=0.08, p2=0.03*, p3=0.31 |
2 | 4.19±0.48 | 4.12±0.50 | 3.99±0.43 | F=1.24, P=0.29 | p1=0.59, p2=0.18, p3=0.18 |
3 | 4.09±0.33 | 4.03±0.41 | 4.07±0.26 | F=0.198, P=0.82 | p1=0.62, p2=0.88, p3=0.63 |
EGD1 | N=10 | N=160 | N=10 | ||
OVs | 0 (0.0) | 50 (31.2) | 0 (0.0) | MC P=0.334 | p1=0.678 p2=0.157 p3=0.175 |
PHG | 0 (0.0) | 20 (12.5) | 10 (100) | ||
Both | 10 (100) | 60 (37.5) | 0 (0.0) | ||
Free | 0 (0.0) | 30 (18.8) | 0 (0.0) | ||
EGD2 | N=20 | N=70 | |||
OVs | 0 (0.0) | 10 (14.3) | 0 | MC P=0.133 | p1=0.133 p2=.. p3=… |
PHG | 10 (50.0) | 60 (85.7) | 0 | ||
Both | 10 (50.0) | 0 (0.0) | 0 | ||
EGD3 | |||||
PHG | 20 (100.0) | 40 (100.0) | 0 (0.0) |